ARYA Portable Oxygen Concentrator
The ARYA Portable Oxygen Concentrator is a Breath of Fresh Air in the Oxygen Therapy Industry
18 avr. 2022 10h00 HE | ARYA BioMed
DENVER, April 18, 2022 (GLOBE NEWSWIRE) -- ARYA BioMed Corp, a leading manufacturer of oxygen therapy devices, is redefining mobile oxygen with the release of its ARYA Portable Oxygen Concentrator. ...
1.png
Oxygen Market Report: Size, Production, Trends and Forecast to 2030 – IndexBox
12 avr. 2022 05h00 HE | IndexBox, Inc.
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- IndexBox has just published a new report: 'EU – Oxygen - Market Analysis, Forecast, Size, Trends and Insights'. Here is a summary of the report's key...
Facts & Factors.jpg
At 7.7% CAGR, Global Oxygen Market Size & Share To Hit USD 83 Billion Mark by 2028, Says Facts & Factors
24 févr. 2022 08h17 HE | Facts & Factors
NEW YORK, United States, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Oxygen Market - By Form (Solid, Liquid, and Gaseous), By Application...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Doses First Patients in ILD-DLCO Trial
16 déc. 2021 08h59 HE | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Announces Issuance of U.S. Patent 11,185,523
01 déc. 2021 07h02 HE | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Doses First Participants in Altitude Trial
22 nov. 2021 07h02 HE | Diffusion Pharmaceuticals Inc.
CHARLOTTESVILLE, Va., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that...
On the Tarmac
Oxygen Independence and Improved Health Security for Barbados
13 nov. 2021 12h38 HE | World Hope International
Bridgetown, Barbados, Nov. 13, 2021 (GLOBE NEWSWIRE) -- In the face of ongoing COVID-19 cases across the island, the Government of Barbados is partnering with the US Southern Command, World Hope...
xebec square logo.png
Xebec annonce ses résultats financiers pour le troisième trimestre de 2021
11 nov. 2021 07h00 HE | Xebec Adsorption
MONTRÉAL, 11 nov. 2021 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. (TSX : XBC) (« Xebec »), fournisseur mondial de solutions d’énergie propre, a annoncé aujourd’hui ses résultats du troisième...
xebec square logo.png
Xebec Announces Q3 2021 Financial Results
11 nov. 2021 07h00 HE | Xebec Adsorption
MONTREAL, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. (TSX: XBC) ("Xebec"), a global provider of clean energy solutions, announced today its 2021 third quarter results, with the...
DiffusionInc_white background.jpg
Diffusion Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
10 nov. 2021 07h02 HE | Diffusion Pharmaceuticals Inc.
Announces Intent to Develop TSC to Treat Hypoxic TumorsAltitude Trial Expected to Commence in November 2021ILD-DLCO Trial Expected to Commence in Late December 2021 CHARLOTTESVILLE, Va., Nov. ...